These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 16186626

  • 1. Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease.
    Zurbriggen R, Amacker M, Kammer AR, Westerfeld N, Borghgraef P, Van Leuven F, Van der Auwera I, Wera S.
    J Mol Neurosci; 2005; 27(2):157-66. PubMed ID: 16186626
    [Abstract] [Full Text] [Related]

  • 2. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S, Brenn A, Grube M, Niedrig K, Holtfreter S, von Bohlen und Halbach O, Groschup M, Keller M, Vogelgesang S.
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [Abstract] [Full Text] [Related]

  • 3. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ, Wang WB, Chen A, Chang Q, Liu S, Zhao M, Wang S, Qiu WY, Pang XB, Xu Q, Sun ZW.
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [Abstract] [Full Text] [Related]

  • 4. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
    Asami-Odaka A, Obayashi-Adachi Y, Matsumoto Y, Takahashi H, Fukumoto H, Horiguchi T, Suzuki N, Shoji M.
    Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
    [Abstract] [Full Text] [Related]

  • 5. Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology.
    Rosenberg RN, Fu M, Lambracht-Washington D.
    Alzheimers Res Ther; 2018 Nov 20; 10(1):115. PubMed ID: 30454039
    [Abstract] [Full Text] [Related]

  • 6. Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.
    Petrushina I, Ghochikyan A, Mktrichyan M, Mamikonyan G, Movsesyan N, Davtyan H, Patel A, Head E, Cribbs DH, Agadjanyan MG.
    J Neurosci; 2007 Nov 14; 27(46):12721-31. PubMed ID: 18003852
    [Abstract] [Full Text] [Related]

  • 7. Oligomeric Forms of Human Amyloid-Beta(1-42) Inhibit Antigen Presentation.
    Gericke C, Mallone A, Engelhardt B, Nitsch RM, Ferretti MT.
    Front Immunol; 2020 Nov 14; 11():1029. PubMed ID: 32582162
    [Abstract] [Full Text] [Related]

  • 8. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    Song Y, Kim HD, Lee MK, Hong IH, Won CK, Bai HW, Lee SS, Lee S, Chung BY, Cho JH.
    PLoS One; 2017 Nov 14; 12(1):e0169509. PubMed ID: 28072821
    [Abstract] [Full Text] [Related]

  • 9. Aβ43 in human Alzheimer's disease: effects of active Aβ42 immunization.
    Jäkel L, Boche D, Nicoll JAR, Verbeek MM.
    Acta Neuropathol Commun; 2019 Sep 02; 7(1):141. PubMed ID: 31477180
    [Abstract] [Full Text] [Related]

  • 10. Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition.
    Das P, Murphy MP, Younkin LH, Younkin SG, Golde TE.
    Neurobiol Aging; 2001 Sep 02; 22(5):721-7. PubMed ID: 11705631
    [Abstract] [Full Text] [Related]

  • 11. Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice.
    Rasool S, Martinez-Coria H, Milton S, Glabe CG.
    Mol Neurobiol; 2013 Dec 02; 48(3):931-40. PubMed ID: 23771815
    [Abstract] [Full Text] [Related]

  • 12. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
    Ding L, Meng Y, Zhang HY, Yin WC, Yan Y, Cao YP.
    Neurosci Lett; 2016 Nov 10; 634():1-6. PubMed ID: 27693663
    [Abstract] [Full Text] [Related]

  • 13. Development and characterization of a TAPIR-like mouse monoclonal antibody to amyloid-beta.
    Wang J, Hara H, Makifuchi T, Tabira T.
    J Alzheimers Dis; 2008 Jun 10; 14(2):161-73. PubMed ID: 18560128
    [Abstract] [Full Text] [Related]

  • 14. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY, Li B, Peng D, Wang CY, Wang GY, Li P, Le YY, Wang JM, Ye G, Chen JH.
    PLoS One; 2017 Jun 10; 12(6):e0180076. PubMed ID: 28662102
    [Abstract] [Full Text] [Related]

  • 15. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL, Tung YC, Liu F, Gong CX, Iqbal K.
    Alzheimers Res Ther; 2017 Jan 10; 9(1):1. PubMed ID: 28073379
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic active immunization with a novel epitope vaccine improves cognitive ability by decreasing amyloid plaques and neuroinflammation in APP/PS1 transgenic mice.
    Ding L, Meng Y, Zhang HY, Yin WC, Yan Y, Cao YP.
    Neurosci Res; 2017 Jun 10; 119():7-14. PubMed ID: 28111220
    [Abstract] [Full Text] [Related]

  • 17. A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer's disease.
    Zhang J, Wu X, Qin C, Qi J, Ma S, Zhang H, Kong Q, Chen D, Ba D, He W.
    Neurobiol Dis; 2003 Dec 10; 14(3):365-79. PubMed ID: 14678754
    [Abstract] [Full Text] [Related]

  • 18. Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease.
    Wang CM, Devries S, Camboni M, Glass M, Martin PT.
    Neurobiol Dis; 2010 Sep 10; 39(3):409-22. PubMed ID: 20493257
    [Abstract] [Full Text] [Related]

  • 19. An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.
    Sigurdsson EM, Knudsen E, Asuni A, Fitzer-Attas C, Sage D, Quartermain D, Goni F, Frangione B, Wisniewski T.
    J Neurosci; 2004 Jul 14; 24(28):6277-82. PubMed ID: 15254082
    [Abstract] [Full Text] [Related]

  • 20. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Cattepoel S, Hanenberg M, Kulic L, Nitsch RM.
    PLoS One; 2011 Apr 05; 6(4):e18296. PubMed ID: 21483675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.